Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
EPS for Minerva Neurosciences (NERV)
EPS in 2023 (TTM): -$4.98
According to Minerva Neurosciences 's latest financial reports the company's current EPS (TTM) is -$4.98. In 2022 the company made an earnings per share (EPS) of -$6.01 an increase over its 2021 EPS that were of -$9.37.
EPS history for Minerva Neurosciences from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.98 | -17.14% |
| 2022 | -$6.01 | -35.86% |
| 2021 | -$9.37 | -1773.21% |
| 2020 | $0.56 | -103.76% |
| 2019 | -$14.88 | 44.19% |
| 2018 | -$10.32 | 53.57% |
| 2017 | -$6.72 | -15.15% |
| 2016 | -$7.92 | -15.38% |
| 2015 | -$9.36 | -55.69% |
| 2014 | -$21.12 | 1379.43% |
| 2013 | -$1.43 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $1.90 | -138.15% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.87 | -117.47% | 🇺🇸 USA |
 Clovis Oncology CLVS | -$1.89 | -62.05% | 🇺🇸 USA |